Literature DB >> 18729234

Myotonic dystrophy protein kinase is expressed in embryonic myocytes and is required for myotube formation.

Erin B Harmon1, Michelle L Harmon, Tricia D Larsen, Alicia F Paulson, M Benjamin Perryman.   

Abstract

Myotonic dystrophy (DM1) is a multi-systemic disease caused by a triplet nucleotide repeat expansion in the 3' untranslated region of the gene coding for myotonic dystrophy protein kinase (DMPK). The primary pathophysiology of DM1 is thought to result from RNA transport and processing defects. The function of DMPK in development or any potential role in DM1 remains unknown. Here we report a novel role for DMPK in myogenesis. We have discovered a specific expression pattern of DMPK in mouse and chick embryonic development. DMPK is expressed in postmitotic cardiac and skeletal myocytes and developmental signaling centers. During cardiac myocyte maturation, DMPK migrates from perinuclear to cellular membrane localization. Manipulating DMPK levels in cultured cardiac and skeletal myocytes has revealed a key role for DMPK in myocyte differentiation. Overexpression of DMPK induces cell rounding and apoptosis in myocytes. In addition, DMPK is necessary for myogenin expression in differentiating C2C12 myoblasts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18729234     DOI: 10.1002/dvdy.21653

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  6 in total

1.  Myotonic dystrophy protein kinase is critical for nuclear envelope integrity.

Authors:  Erin B Harmon; Michelle L Harmon; Tricia D Larsen; Jie Yang; Joseph W Glasford; M Benjamin Perryman
Journal:  J Biol Chem       Date:  2011-09-26       Impact factor: 5.157

2.  Epigenetics of the myotonic dystrophy-associated DMPK gene neighborhood.

Authors:  Lauren Buckley; Michelle Lacey; Melanie Ehrlich
Journal:  Epigenomics       Date:  2016-01-12       Impact factor: 4.778

3.  A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle.

Authors:  Anke E E G Gudde; Anchel González-Barriga; Walther J A A van den Broek; Bé Wieringa; Derick G Wansink
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

4.  Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1.

Authors:  Stefan Hintze; Lisa Knaier; Sarah Limmer; Benedikt Schoser; Peter Meinke
Journal:  Front Physiol       Date:  2018-10-30       Impact factor: 4.566

5.  Intrinsic Myogenic Potential of Skeletal Muscle-Derived Pericytes from Patients with Myotonic Dystrophy Type 1.

Authors:  Cornelia Rosanne Maria Ausems; Renée Henrica Lamberta Raaijmakers; Walterus Johannes Antonius Adriana van den Broek; Marieke Willemse; Baziel Gerardus Maria van Engelen; Derick Gert Wansink; Hans van Bokhoven
Journal:  Mol Ther Methods Clin Dev       Date:  2019-09-12       Impact factor: 6.698

Review 6.  Muscle wasting in myotonic dystrophies: a model of premature aging.

Authors:  Alba Judith Mateos-Aierdi; Maria Goicoechea; Ana Aiastui; Roberto Fernández-Torrón; Mikel Garcia-Puga; Ander Matheu; Adolfo López de Munain
Journal:  Front Aging Neurosci       Date:  2015-07-09       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.